The frequency and intensity of SMARCC1 staining increased borderline significantly (P=0.078, Fisher's exact test) from adenoma to adenocarcinoma, but not from adenocarcinoma to liver metastases (Figure 4D). This evidence concerns the gene SMARCC1 and adenocarcinoma.